(±)4-HDHA

CAS No. 90906-40-4

(±)4-HDHA( —— )

Catalog No. M34865 CAS No. 90906-40-4

(±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (±)4-HDHA
  • Note
    Research use only, not for human use.
  • Brief Description
    (±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.
  • Description
    (±)4-HDHA (4-Hydroxy docosahexaenoic acid) is a PPARγ agonist with anti-inflammatory activity that directly inhibits endothelial cell proliferation and sprouting angiogenesis via PPARγ, which can be used in the study of diabetes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    90906-40-4
  • Formula Weight
    344.49
  • Molecular Formula
    C22H32O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(=C/C(CCC(O)=O)O)\C=C/C/C=C\C/C=C\C/C=C\C/C=C\CC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD2461

    AZD2461 is a novel PARP inhibitor.

  • Furegrelate sodium

    Furegelate sodium is a selective thromboxane synthase inhibitor with oral activity.

  • Ciglitazone

    Ciglitazone (ADD 3878) is a potent and selective PPARγ agonist (EC50: 3 μM) and oral hypoglycemic agent.